Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $342393.0.

  • Nuvation Bio's Shares Outstanding (Diluted Average) rose 2515.97% to $342393.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $342393.0, marking a year-over-year increase of 2515.97%. This contributed to the annual value of $268772.0 for FY2024, which is 2279.42% up from last year.
  • As of Q3 2025, Nuvation Bio's Shares Outstanding (Diluted Average) stood at $342393.0, which was up 2515.97% from $340746.0 recorded in Q2 2025.
  • Nuvation Bio's 5-year Shares Outstanding (Diluted Average) high stood at $342393.0 for Q3 2025, and its period low was $218741.0 during Q1 2023.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $244738.0 (2024), whereas its average is $263934.4.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first increased by 14.03% in 2024, then skyrocketed by 5458.35% in 2025.
  • Over the past 3 years, Nuvation Bio's Shares Outstanding (Diluted Average) (Quarter) stood at $218880.0 in 2023, then rose by 22.79% to $268772.0 in 2024, then grew by 27.39% to $342393.0 in 2025.
  • Its Shares Outstanding (Diluted Average) was $342393.0 in Q3 2025, compared to $340746.0 in Q2 2025 and $338612.0 in Q1 2025.